InsiderClue
← All stocks

CORCEPT THERAPEUTICS INC

CORT Net selling
CIK 0001088856 #827 in the set updated 17 Sep 2026
Bought (12 mo)
$3.31M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$102.49M
$29.98M on a plan · $68.79M straight out of an exercise
Sold at will
$3.72M
5 of 108 sales
Net
−$99.17M
−$404.15K against sales at will

By person

14 insiders · 120 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Maduck Sean
See Remarks
—
$23.27M (20) scheduled
−$23.27M
53,938
0.0499%
$6.03M
+37.0%
Mokari Atabak
Chief Financial Officer
—
$18.73M (22) scheduled
−$18.73M
16,304
0.0151%
$1.82M
+30.2%
Guyer William
Chief Development Officer
—
$14.91M (19) scheduled
−$14.91M
4,313
0.0040%
$481.78K
−25.6%
MAHONEY DAVID L
Director
—
$13.94M (5) scheduled
−$13.94M
1,133,539
1.05%
$126.62M
−8.0%
BELANOFF JOSEPH K
Chief Executive Officer
—
$13.79M (11) scheduled
−$13.79M
2,565,489
2.37%
$286.58M
−5.8%
Vieira Roberto Wandenkolk
President, Oncology
—
$6.46M (7) scheduled
−$6.46M
4,242
0.0039%
$473.85K
+4.3%
WILSON JAMES N
Director
—
$3.94M (12) scheduled
−$3.94M
2,539,086
2.35%
$283.63M
−22.8%
BAKER G LEONARD JR
Director
$3.31M (2)
—
+$3.31M
2,241,893
2.07%
$250.43M
+12.0%
Park Kimberly
Director
—
$3.27M (1) scheduled
−$3.27M
0
0.0000%
$0.00
—
Lyon Joseph Douglas
See Remarks
—
$2.83M (9) scheduled
−$2.83M
5,683
0.0053%
$634.81K
−42.6%
Robb Gary Charles
Chief Business Officer
—
$1.16M (1)
−$1.16M
108,666
0.1005%
$12.14M
+47.2%
Swisher Daniel N JR
Director
—
$192.59K (1) scheduled
−$192.59K
0
0.0000%
$0.00
—
Hunt Hazel
Chief Scientific Officer
—
—
—
255,437
0.2363%
$28.53M
+115.4%
Cannon Gillian
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
MAHONEY DAVID L
13 Mar 2026
Director
Exercised, kept
30,000
$5.86
$175.80K
WILSON JAMES N
24 Feb 2026
Director
Exercised, kept
100,000
$3.88
$388.00K
Hunt Hazel
9 Feb 2026
Chief Scientific Officer
Exercised, kept
150,000
$3.88
$582.00K
BAKER G LEONARD JR
27 Jan 2026
Director
Exercised, kept indirect
30,000
$15.15
$454.50K
BAKER G LEONARD JR
27 Jan 2026
Director
Exercised, kept indirect
25,000
$10.50
$262.50K
BAKER G LEONARD JR
27 Jan 2026
Director
Exercised, kept indirect
25,000
$14.08
$352.00K
BAKER G LEONARD JR
27 Jan 2026
Director
Exercised, kept indirect
30,000
$12.13
$363.90K
BAKER G LEONARD JR
27 Jan 2026
Director
Exercised, kept indirect
30,000
$5.86
$175.80K
BELANOFF JOSEPH K
24 Dec 2025
Chief Executive Officer
Exercised, kept
550,000
$3.88
$2.13M
Robb Gary Charles
24 Dec 2025
Chief Business Officer
Exercised, kept
145,000
$3.88
$562.60K
Show all 120 transactions →

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 76
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,618,692
History held since 9 Nov 2016